Maysami, S ORCID: https://orcid.org/0000-0002-6506-3972, Wong, R, Pradillo, JM, Denes, A, Dhungana, H, Malm, T, Koistinaho, J, Orset, C, Rahman, M, Rubio, M, Schwaninger, M, Vivien, D, Bath, PM, Rothwell, NJ and Allan, SM (2015) A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke. Journal of Cerebral Blood Flow and Metabolism, 36 (3). 596 - 605.

[img]
Preview
Text
A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke.pdf - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

Stroke represents a global challenge and is a leading cause of permanent disability worldwide. Despite much effort, translation of research findings to clinical benefit has not yet been successful. Failure of neuroprotection trials is considered, in part, due to the low quality of preclinical studies, low level of reproducibility across different laboratories and that stroke co-morbidities have not been fully considered in experimental models. More rigorous testing of new drug candidates in different experimental models of stroke and initiation of preclinical cross-laboratory studies have been suggested as ways to improve translation. However, to our knowledge, no drugs currently in clinical stroke trials have been investigated in preclinical cross-laboratory studies. The cytokine interleukin 1 is a key mediator of neuronal injury, and the naturally occurring interleukin 1 receptor antagonist has been reported as beneficial in experimental studies of stroke. In the present paper, we report on a preclinical cross-laboratory stroke trial designed to investigate the efficacy of interleukin 1 receptor antagonist in different research laboratories across Europe. Our results strongly support the therapeutic potential of interleukin 1 receptor antagonist in experimental stroke and provide further evidence that interleukin 1 receptor antagonist should be evaluated in more extensive clinical stroke trials.

Item Type: Article
Additional Information: This article is distributed under the terms of the Creative Commons Attribution 3.0 License (http://www.creativecommons.org/licenses/by/3.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Uncontrolled Keywords: Acute stroke; inflammation; animal models; neuroprotection; experimental
Subjects: Q Science > Q Science (General)
Q Science > QH Natural history
Divisions: Faculty of Natural Sciences > School of Life Sciences
Related URLs:
Depositing User: Symplectic
Date Deposited: 10 Sep 2019 11:46
Last Modified: 10 Sep 2019 11:46
URI: http://eprints.keele.ac.uk/id/eprint/6790

Actions (login required)

View Item View Item